Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant RecipientsCaroline X. Qin, Dorry L. Segev, Megan K. Morales et al.|Transplantation|2021Cited by 162
mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipientsSunjae Bae, Dorry L. Segev, Jennifer L. Alejo et al.|American Journal of Transplantation|2022Cited by 21
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External ValidationJennifer L. Alejo, Sunjae Bae, Jonathan Mitchell et al.|Transplantation|2022Cited by 17